Published in Hypertens Res on June 16, 2011
Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signal (2012) 1.54
X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates [Ca²⁺]i. J Mol Cell Cardiol (2012) 1.03
Global Gene Expression Profiling Reveals Functional Importance of Sirt2 in Endothelial Cells under Oxidative Stress. Int J Mol Sci (2013) 0.86
Endothelial Barrier and Its Abnormalities in Cardiovascular Disease. Front Physiol (2015) 0.83
Sirtuins, aging, and cardiovascular risks. Age (Dordr) (2015) 0.79
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res (2014) 4.83
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med (2002) 3.74
Effects of pitavastatin in Japanese patients with chronic heart failure: the Pitavastatin Heart Failure Study (PEARL Study). Circ J (2013) 2.75
Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc Interv (2011) 1.85
Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest (2002) 1.80
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation (2004) 1.73
Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol (2005) 1.68
Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation (2007) 1.64
Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation. J Am Coll Cardiol (2004) 1.55
Vascular failure: A new clinical entity for vascular disease. J Hypertens (2006) 1.52
Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension. Hypertens Res (2013) 1.51
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency. Hypertens Res (2008) 1.51
A 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitor reduces hypertensive nephrosclerosis in stroke-prone spontaneously hypertensive rats. J Hypertens (2002) 1.47
Noninvasive method for assessing the human circadian clock using hair follicle cells. Proc Natl Acad Sci U S A (2010) 1.43
Postprandial hyperglycemia is a possible contributor to paroxysmal atrial fibrillation: a case report. J Cardiol (2006) 1.42
Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J (2009) 1.42
Low-density lipoprotein subfractions and the prevalence of silent lacunar infarction in subjects with essential hypertension. Hypertens Res (2006) 1.41
Association between N-terminal pro B-type natriuretic peptide and day-to-day blood pressure and heart rate variability in a general population: the Ohasama study. J Hypertens (2015) 1.39
Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol (2011) 1.35
Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation. Am J Physiol Heart Circ Physiol (2002) 1.31
Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients. Biochem Biophys Res Commun (2005) 1.21
Involvement of the protein kinase CK2 in the regulation of mammalian circadian rhythms. Sci Signal (2009) 1.21
The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells. Atherosclerosis (2012) 1.17
Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice. J Biol Chem (2010) 1.16
Flow-mediated vasodilation as a diagnostic modality for vascular failure. Hypertens Res (2008) 1.12
Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening. Atherosclerosis (2007) 1.11
Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis (2006) 1.10
Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers. Can J Physiol Pharmacol (2006) 1.09
Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study. Cardiovasc Diabetol (2010) 1.08
Isoprenylcysteine carboxyl methyltransferase modulates endothelial monolayer permeability: involvement of RhoA carboxyl methylation. Circ Res (2003) 1.07
Predictive value of high-molecular weight adiponectin in subjects with a higher risk of the development of metabolic syndrome: from a population based 5-year follow-up data. Int J Cardiol (2012) 1.07
High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol (2007) 1.05
Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol (2012) 1.05
Mitogen-activated protein kinase is a functional component of the autonomous circadian system in the suprachiasmatic nucleus. J Neurosci (2008) 1.04
Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol (2007) 1.03
Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ J (2002) 1.03
HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke (2003) 1.03
Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler Thromb Vasc Biol (2002) 1.03
Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation (2004) 1.01
Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease. Am J Med Sci (2007) 0.99
Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats. Hypertension (2003) 0.99
Sphingosine 1-phosphate induces alpha-smooth muscle actin expression in lung fibroblasts via Rho-kinase. Kobe J Med Sci (2005) 0.99
Opening of Ca2+-activated K+ channels is involved in ischemic preconditioning in canine hearts. J Mol Cell Cardiol (2004) 0.97
Effects of sitagliptin beyond glycemic control: focus on quality of life. Cardiovasc Diabetol (2013) 0.97
Low serum albumin level is risk factor for patients with percutaneous endoscopic gastrostomy. Intern Med (2010) 0.96
Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease. Atherosclerosis (2008) 0.95
Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice. Hypertension (2003) 0.95
IL-13 attenuates vascular tube formation via JAK2-STAT6 pathway. Circ J (2008) 0.93
Marked cerebral atrophy is correlated with kidney dysfunction in nondisabled adults. Hypertens Res (2010) 0.92
A multicenter study design to assess the clinical usefulness of semi-automatic measurement of flow-mediated vasodilatation of the brachial artery. Int Heart J (2012) 0.92
Prognostic value of pentraxin 3 in patients with chronic heart failure. Int J Cardiol (2007) 0.91
Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase. Circulation (2004) 0.90
Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure. Glycoconj J (2007) 0.90
An anti-proliferative gene BTG1 regulates angiogenesis in vitro. Biochem Biophys Res Commun (2004) 0.90
AMPD1: a novel therapeutic target for reversing insulin resistance. BMC Endocr Disord (2014) 0.89
Marked increase of insulin gene transcription by suppression of the Rho/Rho-kinase pathway. Biochem Biophys Res Commun (2006) 0.89
Effect of insulin-unstimulated diabetic therapy with miglitol on serum cystatin C level and its clinical significance. Diabetes Res Clin Pract (2008) 0.89
Adenoviral transfer of rho family proteins to lung cancer cells ameliorates cell proliferation and motility and increases apoptotic change. Kobe J Med Sci (2007) 0.89
Overexpression of endothelial nitric oxide synthase in endothelial cells is protective against ischemia-reperfusion injury in mouse skeletal muscle. Am J Pathol (2002) 0.88
Fracture of a sirolimus-eluting stent with migration. Int J Cardiol (2008) 0.88
Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study. Am Heart J (2007) 0.87
Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus. Metabolism (2007) 0.87
Alternative spliced variants in the pantetheinase family of genes expressed in human neutrophils. Gene (2008) 0.87
Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy. Am J Hypertens (2007) 0.87
A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population. Hypertension (2008) 0.87
Association between high molecular weight adiponectin levels and metabolic parameters. J Atheroscler Thromb (2009) 0.87
The late-phase inflammatory response after drug-eluting stent implantation. Heart Vessels (2013) 0.87
Angiotensin II increases expression of IP-10 and the renin-angiotensin system in endothelial cells. Hypertens Res (2008) 0.86
Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease. Am J Nephrol (2006) 0.86
Evaluation of serial changes in tissue characteristics during statin-induced plaque regression using virtual histology-intravascular ultrasound studies. Am J Cardiol (2013) 0.86
Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report. Cardiovasc Diabetol (2014) 0.85
Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice. Biochem Biophys Res Commun (2013) 0.85
Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes. Life Sci (2008) 0.84
Effect of exercise therapy on monocyte and neutrophil counts in overweight women. Am J Med Sci (2010) 0.84
Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure. Heart Vessels (2012) 0.84
Establishment of a quantitative, qualitative, and high-throughput analysis of sulfatides from small amounts of sera by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Anal Biochem (2006) 0.83
Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation. Atherosclerosis (2007) 0.83
Activation of matrix metalloproteinase-9 is associated with mobilization of bone marrow-derived cells after coronary stent implantation. Int J Cardiol (2010) 0.82
Eicosapentaenoic acid increases cytochrome P-450 2J2 gene expression and epoxyeicosatrienoic acid production via peroxisome proliferator-activated receptor γ in endothelial cells. J Cardiol (2009) 0.82
Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart. J Am Coll Cardiol (2002) 0.82
Tropical fruit camu-camu (Myrciaria dubia) has anti-oxidative and anti-inflammatory properties. J Cardiol (2008) 0.82
Estimated glomerular filtration rate as a predictor of secondary outcomes in Japanese patients with coronary artery disease. J Cardiol (2009) 0.82
Images in cardiovascular medicine. Mouse coronary angiograph using synchrotron radiation microangiography. Circulation (2002) 0.82
Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening. Thromb Haemost (2006) 0.82
Increased oxidative stress impairs adipose tissue function in sphingomyelin synthase 1 null mice. PLoS One (2013) 0.82
Impaired glucose tolerance: a possible contributor to left ventricular hypertrophy and diastolic dysfunction. Int J Cardiol (2006) 0.82
Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study. Cardiovasc Diabetol (2013) 0.82
An out-of-lab trial: a case example for the effect of intensive exercise on rhythms of human clock gene expression. J Circadian Rhythms (2013) 0.81
IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice. Am J Pathol (2011) 0.81
Eicosapentaenoic acid reduces myocardial injury induced by ischemia and reperfusion in rabbit hearts. J Cardiovasc Pharmacol (2003) 0.81
Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice. Am J Physiol Heart Circ Physiol (2013) 0.81